Prevalence of Human Papilloma Virus (HPV) and Other Risk Factors for the Development of Cervical Cancer in Guatemala

Authors

  • G. Arroyo Departamento de Citohistología, Facultad de Ciencias Quimicas y Farmacia, Universidad de San Carlos de Guatemala
  • F. Zetina Departamento de Citohistología, Facultad de Ciencias Quimicas y Farmacia, Universidad de San Carlos de Guatemala
  • M. Villeda Liga Nacional contra el Cáncer
  • W. Guerra Departamento de Patología, Instituto Nacional de Cancerología (INCAN)
  • R. Daniel Departament of Molecular Microbiology and Immunology, School of Public Health, The Johns Hopkins University
  • K. Kindilien Departament of Molecular Microbiology and Immunology, School of Public Health, The Johns Hopkins University
  • K. Shah Departament of Molecular Microbiology and Immunology, School of Public Health, The Johns Hopkins University

DOI:

https://doi.org/10.54495/Rev.Cientifica.EdicionEspecial2008.190%20

Keywords:

Prevalence, Human Papilloma Virus (HPV), Risk factors, Cervical cancer, Guatemala

Abstract

Cervical cancer is the most common malignancy among women in the third world and in Guatemala, it is responsible for 40% of all cancers in both sexes and 60% of all female cancers. The presence of Human Papilloma Virus (HPV) It is considered, among others, as the most important risk factor for the development of cervical cancer.


The present study was carried out with the purpose of determining the prevalence of HPV types in a group of Guatemalan patients with cervical cancer, as well as to evaluate the risk factors associated with the development of the disease.


For this purpose, a case-control study was carried out in 112 patients with invasive cervical cancer (cases) and 102 healthy women (controls). Cervical biopsies were obtained and the presence of HPV was investigated using two molecular methods, hybrid capture 2 (HC-2™. Digene Co.) and polymerase chain reaction (PCR). An epidemiological questionnaire was used to assess other risk factors grouped into sexual behavior factors, reproductive factors, and sociodemographic factors. The information was collected during a personal interview with the study subjects.


A total of 89% of the patients and 18% of the controls were positive for Human Papillomavirus DNA, and the most frequently detected types were HPV 16, 18, and 45.

Risk factor assessment showed significant trend p-values ​​(increased risk of developing cervical cancer) for factors such as: early age of onset of sexual intercourse, high number of lifetime sexual partners and stable partners, high number of pregnancies and vaginal deliveries, low schooling and an ethnic origin categorized as indigenous, contrary to others such as prenatal care during the last pregnancy, which is a factor that reduces risk.

Downloads

Download data is not yet available.

References

Parkin, D. M., P. Pisani and J. Ferlay. Global Cancer Statistics. Ca Cancer J Clin 1999,49,33-64, https://doi.org/10.3322/canjclin.49.1.33

Registro Nacional del Cáncer de Guatemala. Informes de años 1.993 y 1994. Liga Nacional Contra el Cáncer. 1997.

Bosch, F. X.. Muñoz, N., De Sanioso. S. & Shah, K.V What is relevant in cervical carcinogenesis other than HPV? In: Monsonego, J. ed. Papillomavirus in Human Pathology. Challenges of Modern Medicine 1994, pp. 173-181.

Bosch, F.X., De SanJosé, S.. Catellsage, X. N. Muñoz. Geographical and Social Patterns of Cervical Cancer Incidence. In: New Developments in Cervical Cancer Screening and Prevention. Ed. Franco Monsonego 1997, pp. 23-33.

Torroella-Kouri, M., Morsberger, S., Carrillo, el al. HPV Prevalence among Mexican Women with Neoplastic and Normal Cervixes. Gynecol Oncol 1998, 70: 115-120, https://doi.org/10.1006/gyno.1998.5055

Munoz, N,, Bosch, F.X., De SanJosé, S, el al. Risk factor for cervical cancer in Colombia and Spain. Int J Cancer 1992, 52,750-758, https://doi.org/10.1002/ijc.2910520514

Herrero, R... Brinton L. A, Reeves W. C., et al. Factores de Riesgo de Carcinoma Invasor del Cuello Uterino en America Latina. Bol Of Sanit Panam 1992, 190(1),6-26.

Walboomers, J, M. M., Jacobs M. V.,Manos M. M., et al. Human Papillomavirus is a necessary cause of Invasive Cervical Cancer Worldwide. J Pa thol 1999, 189:12-129, https://doi.org/10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F

Gravitt, P.E., Peyton. C.L., Apple, R.J. and Wheeler C.M. Genotyping of 27 Human Papillomavirus by Using LI consensus PCR Product by a Single Hybridization Reverse Line Blot Detection Method. J Clin Microbiol 1998, 36(10), 3020-3027, https://doi.org/10.1128/JCM.36.10.3020-3027.1998

Lorincz, A.T. Methods of DNA Hybridization and their Clinical Applicability to Human Papillomavirus Detection. In; New Developments in Cervical Cancer Screening and Prevention. Ed. Franco Monsonego 1997, pp. 325-337.

Gravitt P.E., C.L. Peyton, T. Q. Alessi, et al. Improved Amplification of Genital Human Papillomaviruses. J Clin Microbiol 2000. 38(1): 357-361, https://doi.org/10.1128/JCM.38.1.357-361.2000

Published

2008-12-31

How to Cite

Arroyo, G., Zetina, F., Villeda, M., Guerra, W., Daniel, R., Kindilien, K., & Shah, K. (2008). Prevalence of Human Papilloma Virus (HPV) and Other Risk Factors for the Development of Cervical Cancer in Guatemala. Revista Científica, 51–57. https://doi.org/10.54495/Rev.Cientifica.EdicionEspecial2008.190

Issue

Section

Artículos originales